Monitor for the actual execution of this sale on Form 4 filings. A sale of this size by a top venture holder could signal reduced conviction or a portfolio rebalancing; watch for follow-on selling by other insiders or funds.
Price Chart
Executive Summary
Qiming Venture Partners VI, L.P., a major venture backer of Alamar Biosciences, filed a Form 144 notice of intent to sell 1,558,858 shares of common stock, with an approximate market value of $36.7 million based on the filing date. This represents a substantial portion of the fund's holdings and signals a significant insider monetization event, though the sale is not yet executed.
Key Facts
- Qiming Venture Partners VI, L.P. filed Form 144 to sell 1,558,858 shares of Alamar Biosciences common stock.
- Estimated aggregate market value of the proposed sale is approximately $36,664,000.
- Shares were acquired through conversion of Series A-3, A-4, and Series B preferred shares upon the company's IPO.
- The selling entity is a venture capital fund and an affiliate of the issuer.
- The filing date is October 14, 2026.
Financial Impact
Proposed sale of ~1.56M shares valued at ~$36.7M, representing a material portion of Qiming's stake.
Risk Factors
- Large insider sale may pressure the stock if executed in the open market.
- Form 144 is only an intent to sell; the sale may not occur or may be smaller than indicated.
- Venture fund selling is common post-IPO but the magnitude relative to float could be significant.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001231919-26-001455 |
| Document: 0001231919-26-001455-index.html | 0001231919-26-001455 |
| Document: 0001231919-26-001455.txt | 0001231919-26-001455 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers